Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
- 22 July 1994
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 265 (5171) , 528-530
- https://doi.org/10.1126/science.7518614
Abstract
Two molecular mechanisms of T cell-mediated cytotoxicity, one perforin-based, the other Fas-based, have been demonstrated. To determine the extent of their contribution to T cell-mediated cytotoxicity, a range of effector cells from normal control or perforin-deficient mice were tested against a panel of target cells with various levels of Fas expression. All cytotoxicity observed was due to either of these mechanisms, and no third mechanism was detected. Thus, the perforin- and Fas-based mechanisms may account for all T cell-mediated cytotoxicity in short-term in vitro assays.Keywords
This publication has 22 references indexed in Scilit:
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway?European Journal of Immunology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.The Journal of Experimental Medicine, 1993
- Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions.The Journal of Experimental Medicine, 1992
- Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme ACell, 1992
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- The molecular mechanism of lymphocyte-mediated tumor cell lysisImmunology Today, 1985
- Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.The Journal of Experimental Medicine, 1978
- REJECTION OF ASCITES TUMOR ALLOGRAFTSThe Journal of Experimental Medicine, 1972